Bain, Cinven to acquire Lonza specialty ingredients business in CHF 4.2B deal

Bain Capital Pvt. Equity and Cinven Ltd. agreed to acquire Lonza's specialty ingredients business for a total enterprise value of CHF 4.2 billion.

Basel, Switzerland-headquartered Lonza Specialty Ingredients provides specialty chemicals for microbial control solutions. It has about 2,800 employees, 11 research and development centers and 17 manufacturing sites globally.

The deal is expected to close in the second half of 2021, subject to customary closing conditions.

Advisers to the buyer group include Kirkland & Ellis, Freshfields, Lenz & Staehelin, Ernst & Young, Boston Consulting Group, Alvarez & Marsal, ERM, Nexant, The Valence Group of Piper Sandler, Opus Corporate Finance and Trumont.

BofA Securities and UBS are joint financial advisers to Lonza.